Exin Therapeutics
AI drug discovery platform for neurotherapeutics
About Exin Therapeutics
We use AI and high-throughput mouse studies to discover therapeutics that modify neural activity in the brain. The initial focus is on epilepsies associated with autism and Parkinson’s disease with the potential to expand to any neurological disorder underlined by a dysfunction in neural activity. Our R&D is guided by AI models trained on high-density multimodal mouse data generated in-house.
We are 3 Oxford-trained neuroscientists supported by an experienced SAB from Harvard, Science Corp (ex-Neuralink), EPFL, Meta, and UCL.
In 1.5 months since landing in SF, we went from nothing to (1) opening and operating an animal lab in South SF, (2) obtaining a proof-of-concept in mice, (3) building a multimodal AI model that directs our screening approach and (4) submitting two provisional patents; all while utilizing less than 50% of our YC funding.
Company details
Funding
Total raised
$500K
Last stage
Seed
Investors
Founders
Marko Tvrdic
Cofounder & COO @ Exin Therapeutics. Worked across analysis levels in bio – from molecules to complex behavior. Previously, I worked on retinal and circadian rhythm disorders, neurodevelopment, and systems and comp neuro, with a small stint in venture. Oxford MSc + PhD (on leave to build Exin).
LinkedIn
Gabriel Ocana Santero
Neuroscientist with a PhD in Pharmacology from Oxford University. Background in biochemistry, gene therapy, neurodevelopmental disorders, and neuroAI. Former Marie Skłodowska-Curie ESR and 'la Caixa' foundation fellow.
LinkedIn
Ivan Lazarte
Physicist and neuroscientist with a DPhil in Physiology, Anatomy, and Genetics from Oxford University (Clarendon Scholar). Background spans optical physics, biophysical modeling, visual neuroscience, and interneuron development.
LinkedInWhat happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.